Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...
The company also reported that its fourth quarter revenues dropped 7 percent from a year ago, while its full-year 2024 revenues declined 3 percent.
The company also reported that its fourth quarter revenues dropped 7 percent from a year ago, while full-year 2024 revenues declined 3 percent.
The Accelerate WAVE system is designed to provide rapid antimicrobial susceptibility testing (AST) directly from positive blood culture bottles and bacterial isolate colonies. The WAVE system is ...
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...
Typically, healthcare professionals prescribe antibiotics, such as amoxicillin, doxycycline, and cefuroxime axetil, to treat the early stages of Lyme disease.
In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
Dr Samuel Kow Donkoh, the President, Pharmaceutical Society of Ghana, has cautioned the public against the intake of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback